These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7673493

  • 1. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Stricker RB, Goldberg B, Mills LB, Epstein WL.
    J Am Acad Dermatol; 1995 Oct; 33(4):608-11. PubMed ID: 7673493
    [Abstract] [Full Text] [Related]

  • 2. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
    Raszka WV, Moriarty RA, Ottolini MG, Waecker NJ, Ascher DP, Cieslak TJ, Fischer GW, Robb ML.
    J Pediatr; 1996 Aug; 129(2):245-50. PubMed ID: 8765622
    [Abstract] [Full Text] [Related]

  • 3. Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil.
    Traub A, Margulis SB, Stricker RB.
    Dermatology; 1997 Aug; 195(4):369-73. PubMed ID: 9529559
    [Abstract] [Full Text] [Related]

  • 4. Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene.
    Stricker RB, Elswood BF, Goldberg B, Dumlao C, Van Elk J, Henry J, Winger EE, Epstein WL.
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):462-6. PubMed ID: 8077474
    [Abstract] [Full Text] [Related]

  • 5. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection.
    Stricker RB, Zhu YS, Elswood BF, Dumlao C, Van Elk J, Berger TG, Tappero J, Epstein WL, Kiprov DD.
    Immunol Lett; 1993 Apr; 36(1):1-6. PubMed ID: 8102123
    [Abstract] [Full Text] [Related]

  • 6. Delayed-type hypersensitivity testing in Tanzanian adults with HIV infection.
    Miller WC, Thielman NM, Swai N, Cegielski JP, Shao J, Ting D, Mlalasi J, Manyenga D, Lallinger GJ.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):303-8. PubMed ID: 8673536
    [Abstract] [Full Text] [Related]

  • 7. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D.
    Arch Intern Med; 1995 Oct 23; 155(19):2111-7. PubMed ID: 7575072
    [Abstract] [Full Text] [Related]

  • 8. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.
    Blatt SP, Hendrix CW, Butzin CA, Freeman TM, Ward WW, Hensley RE, Melcher GP, Donovan DJ, Boswell RN.
    Ann Intern Med; 1993 Aug 01; 119(3):177-84. PubMed ID: 8100691
    [Abstract] [Full Text] [Related]

  • 9. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Smith KJ, Vidmar D, Skelton HG, Hackley BE.
    J Am Acad Dermatol; 1996 Sep 01; 35(3 Pt 1):491-3. PubMed ID: 8784300
    [No Abstract] [Full Text] [Related]

  • 10. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
    Vonderheid EC, Ekbote SK, Kerrigan K, Kalmanson JD, Van Scott EJ, Rook AH, Abrams JT.
    J Invest Dermatol; 1998 Jun 01; 110(6):946-50. PubMed ID: 9620303
    [Abstract] [Full Text] [Related]

  • 11. Delayed-type hypersensitivity skin test responses to PPD and other antigens among BCG-vaccinated HIV-1-infected and healthy children and adolescents.
    Costa NM, Albuquerque Md, Lins JB, Alvares-Junior JT, Stefani MM.
    Rev Soc Bras Med Trop; 2011 Oct 01; 44(5):542-5. PubMed ID: 21877065
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conditioned immunosuppressive effect of cyclophosphamide on delayed-type hypersensitivity response and a preliminary analysis of its mechanism.
    Mei L, Li L, Li Y, Deng Y, Sun C, Ding G, Fan S.
    Neuroimmunomodulation; 2000 Oct 01; 8(1):45-50. PubMed ID: 10859488
    [Abstract] [Full Text] [Related]

  • 16. Decrease in viral load associated with topical dinitrochlorobenzene therapy in HIV disease.
    Stricker RB, Goldberg B, Mills LB, Epstein WL.
    Res Virol; 1997 Oct 01; 148(5):343-8. PubMed ID: 9403933
    [Abstract] [Full Text] [Related]

  • 17. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT, Sparks FC, Eilber FR, Morton DL.
    Cancer; 1975 Mar 01; 35(3):748-55. PubMed ID: 1111942
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlations between DNCB skin hypersensitivity and leukocyte migration inhibition by DNCB-coated human erythrocytes.
    Walewski J, Nowakowska A.
    Arch Immunol Ther Exp (Warsz); 1981 Mar 01; 29(1):29-33. PubMed ID: 7283677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.